I you the same answer I gave Hot tuna
Hot Tuna has been consistent in his view yet QIN has survived a much more perilous period in 2012 when CBA pulled the plug.
Now the coy is on the cusp of volume high value product supply of the traditional market with its major competitor facing a reduced supply due to over harvesting. QIN's other developing market i.e. organic medical products is also maturing as its proceeds through FDA Stage 3 for one product and Stage 2 for others.
As far as I can see the long term fundamentals are sound and the issue revolves around short term liquidity. So the deal forthcoming needs to address that plus provide the best outcome possible for existing shareholders.
I await this and if it involves a cap raising I will favourably review participating,
All IMO and DYOR
- Forums
- ASX - By Stock
- QIN
- Ann: Update of put option and loan repayment recovery
Ann: Update of put option and loan repayment recovery, page-168
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online